STOCK TITAN

CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Rhea-AI Summary

CAMP4 Therapeutics (Nasdaq: CAMP) granted options covering 30,000 common shares to two newly hired employees on November 16, 2026.

The employment inducement grants carry a $3.86 exercise price, equal to the stock’s closing price on the grant date, and a ten-year term. Vesting spans four years: 25% vests on the first anniversary of each employee’s employment start, followed by 36 equal monthly installments, subject to continued service. The grants fall under the 2026 Inducement Plan and Nasdaq Listing Rule 5635(c)(4).

Loading...
Loading translation...

Positive

  • None.

Negative

  • Minor point. Forward-looking: it has not happened yet and may not happen.Options covering 30,000 shares at a $3.86 exercise price create potential dilution if exercised.

Key Figures

Option shares: 30,000 shares Exercise price: $3.86 per share Option term: 10 years +3 more
Option shares
30,000 shares
Granted to two newly hired employees
Exercise price
$3.86 per share
Equal to the Nov. 16 closing price; matches the prior daily close
Option term
10 years
Term of each inducement grant
Vesting period
4 years
Subject to continued employee service
Initial vesting
25%
Vests on the one-year anniversary of the employee’s first day
Subsequent vesting installments
36 equal monthly installments
Remaining option shares vest after the initial one-year anniversary

Key Terms

non-qualified stock options, nasdaq listing rule 5635(c)(4)
2 terms
non-qualified stock options financial
"granted non-qualified stock options to purchase 30,000 shares"
Non-qualified stock options are a type of employee benefit that gives individuals the right to buy company shares at a set price, usually lower than the market value, within a certain period. Unlike other options that may have special tax advantages, these options are taxed as income when exercised, which can affect how much money the employee or investor ultimately gains. They are important because they can influence company compensation strategies and impact the financial outcomes for employees and investors.
nasdaq listing rule 5635(c)(4) regulatory
"in accordance with Nasdaq Listing Rule 5635(c)(4)"
NASDAQ Listing Rule 5635(c)(4) is a rule that requires a company to get approval from its shareholders before selling a large amount of its shares, usually over 20%. This helps protect investors by making sure the company doesn't flood the market with new shares without their say, which could lower the stock's value.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

WATERTOWN, Mass., Nov. 17, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on November 16, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase 30,000 shares of the Company’s common stock to two newly hired employees of the Company, each as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grants”).

The Inducement Grants each have a ten-year term and an exercise price per share of $3.86, which is equal to the closing price of CAMP4’s common stock as of the Grant Date. The Inducement Grants will vest over a four-year period, with 25% of the shares vesting on the one-year anniversary of the employee’s first day of employment with the Company, and thereafter the remainder of the option will vest in 36 equal monthly installments, subject to the employee’s continued service with CAMP4 through the applicable vesting dates. The Inducement Grants were granted pursuant to, and are subject to, the terms and conditions of the Company’s 2026 Inducement Plan and the applicable non-qualified stock option agreement.

About CAMP4 Therapeutics 
CAMP4 is developing disease-modifying treatments for a broad range of genetic diseases where amplifying healthy protein may offer therapeutic benefits. Our approach amplifies mRNA by harnessing a fundamental mechanism of how genes are controlled. To amplify mRNA, our therapeutic ASO drug candidates target regulatory RNAs (regRNAs), which act locally on transcription factors and are the master regulators of gene expression. CAMP4’s proprietary RAP Platform® enables the mapping of regRNAs and generation of therapeutic candidates designed to target the regRNAs associated with genes underlying haploinsufficient and recessive partial loss-of-function disorders, of which there are more than 1,200, in which a modest increase in protein expression may have the potential to be clinically meaningful. For more information, visit camp4tx.com.

Contacts

Investor Relations:
Sara Michelmore
Milestone Advisors
sara@milestone-advisorsllc.com

Media:
Sofia Bermudez
LifeSci Communications
sbermudez@lifescicomms.com


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What are the terms of CAMP4’s November 2026 employee inducement options?

CAMP4 granted options covering 30,000 common shares to two newly hired employees on November 16, 2026, with a $3.86 exercise price and a ten-year term.

How do CAMP4’s November 2026 inducement options vest?

The options vest over four years, subject to continued service through each applicable vesting date. The first 25% vests on the first anniversary of each employee’s employment start, and the remainder vests in 36 equal monthly installments.

Keep reading